An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

NCT02290301 · clinicaltrials.gov ↗

COMPLETED

Status

5180

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: gemigliptin

Sponsor

LG Life Sciences